- Home
- All Courses
- Pharmacy
- Pharmacology
- Clinical pharmacology part 2
Curriculum
- 12 Sections
- 81 Lessons
- 48 Weeks
Expand all sectionsCollapse all sections
- Analgesics module12
- 1.1Introduction to Analgesics12 Minutes
- 1.2Opioid analgesics12 Minutes
- 1.3Pure opioid agonists part 119 Minutes
- 1.4Pure opioid agonists part 219 Minutes
- 1.5Partial opioid agonists6 Minutes
- 1.6Pure opioid antagonists15 Minutes
- 1.7NSAIDs29 Minutes
- 1.8Aspirin31 Minutes
- 1.9Non selective NSAIDs12 Minutes
- 1.10Selective COX-2 inhibitors7 Minutes
- 1.11Paracetamol11 Minutes
- 1.12Analgesic module quiz
- Central nervous system module - Chapter 1: Anxiolytics and sedative hypnotics8
- 2.1Lesson 1: Classification of Anxiolytics and sedative hypnotics8 Minutes
- 2.2Lesson 2: GABA receptors16 Minutes
- 2.3Lesson 3: Barbiturates17 Minutes
- 2.4Lesson 4: Benzodiazepines classification and Uses13 Minutes
- 2.5Lesson 5 : Benzodiazepines adverse effects5 Minutes
- 2.6Lesson 6: Zolpidem , Zaleplon6 Minutes
- 2.7Lesson 7: Buspirone4 Minutes
- 2.8Lesson 8: Ramelteon5 Minutes
- Central nervous system module - Chapter 2: Antidepressants12
- 3.1Pathogenesis of depression18 Minutes
- 3.2Mechanism of action of antidepressants23 Minutes
- 3.3TCA15 Minutes
- 3.4SSRI13 Minutes
- 3.5Bupropion6 Minutes
- 3.6SNRI4 Minutes
- 3.7Mirtazapine9 Minutes
- 3.8MAO inhibitors15 Minutes
- 3.9Agomelatine4 Minutes
- 3.10Uses of antidepressants3 Minutes
- 3.11Guidelines for the use of antidepressants7 Minutes
- 3.12Lithium29 Minutes
- Central nervous system module - Chapter 3: Antipsychotics5
- Central nervous system module - Chapter 4: Epilepsy6
- Central nervous system module - Chapter 5: Antiparkinsonian drugs7
- 6.1Pathogenesis of Parkinson disease
- 6.2Clinical picture of Parkinson disease11 Minutes
- 6.3Drug therapy of Parkinson disease
- 6.4L-dopa23 Minutes
- 6.5Dopaminergic drugs used in Parkinson disease16 Minutes
- 6.6Anticholinergic drugs used in Parkinson disease7 Minutes
- 6.7Management strategy of patients with Parkinson disease
- Central nervous system module - Chapter 6: Alzheimer disease3
- Central nervous system module - Chapter 7: Multiple sclerosis2
- Central nervous system module - Chapter 8: Amyotrophic lateral sclerosis2
- Central nervous system module - Chapter 9: Migraine1
- Gastrointestinal tract module11
- 11.1Pathogenesis of peptic ulcer
- 11.2Drug therapy of peptic ulcer
- 11.3Proton pump inhibitors
- 11.4Mucosal protective drugs
- 11.5Anti H.pylori drug therapy
- 11.6Antiemetics: pathogenesis of vomiting
- 11.7Antiemetics: Classification
- 11.8Antiemetics: Metoclopramide
- 11.9Antiemetics: Domperidone
- 11.10Hepatic encephalopathy
- 11.11Esophageal varices
- Respiratory tract module - Bronchial asthma12
- 12.1Pathogenesis of bronchial asthma
- 12.2Classification of Short term relievers
- 12.3Short acting Beta 2 agonists (SABA)
- 12.4Antimuscarinics
- 12.5Methyl xanthines
- 12.6Classification of long term controllers
- 12.7Glucocorticoids
- 12.8Leukotriene pathway inhibitors
- 12.9Cromolyn, Nedocromil
- 12.10Omalizumab
- 12.11Management of acute exacerbation of bronchial asthma
- 12.12Long term management of bronchial asthma
Pathogenesis of bronchial asthma
The lesson content is empty.